Global Respiratory Syncytial Virus Vaccines Market Growth (Status and Outlook) 2022-2028
- LP 4956371
- 103 Pages
- May 2022
- Medical Devices
The United States Respiratory Syncytial Virus Vaccines market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global Respiratory Syncytial Virus Vaccines market, reaching US$ million by the year 2028. As for the Europe Respiratory Syncytial Virus Vaccines landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Respiratory Syncytial Virus Vaccines players cover Pfizer Inc.Pfizer Inc., Sanofi, Merck Sharp & Dohme, and GlaxoSmithKline, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Syncytial Virus Vaccines market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Palivizumab
RSVpreF PF06928316
RSVPreF3 OA (GSK3844766A)
mRNA-1345
Janssen RSV Vaccine
ResVax
Nirsevimab (MEDI8897)
MVA-BN RSV
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Research Institute
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Pfizer Inc.Pfizer Inc.
Sanofi
Merck Sharp & Dohme
GlaxoSmithKline
SOBI
Johnson & Johnson
Bavarian Nordic
Novavax
AstraZeneca
Moderna
Codagenix
Intravacc
Alphavax
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Respiratory Syncytial Virus Vaccines Market Size 2017-2028
2.1.2 Respiratory Syncytial Virus Vaccines Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Respiratory Syncytial Virus Vaccines Segment by Type
2.2.1 Palivizumab
2.2.2 RSVpreF PF06928316
2.2.3 RSVPreF3 OA (GSK3844766A)
2.2.4 mRNA-1345
2.2.5 Janssen RSV Vaccine
2.2.6 ResVax
2.2.7 Nirsevimab (MEDI8897)
2.2.8 MVA-BN RSV
2.3 Respiratory Syncytial Virus Vaccines Market Size by Type
2.3.1 Respiratory Syncytial Virus Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2017-2022)
2.4 Respiratory Syncytial Virus Vaccines Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Institute
2.5 Respiratory Syncytial Virus Vaccines Market Size by Application
2.5.1 Respiratory Syncytial Virus Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2017-2022)
3 Respiratory Syncytial Virus Vaccines Market Size by Player
3.1 Respiratory Syncytial Virus Vaccines Market Size Market Share by Players
3.1.1 Global Respiratory Syncytial Virus Vaccines Revenue by Players (2020-2022)
3.1.2 Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Players (2020-2022)
3.2 Global Respiratory Syncytial Virus Vaccines Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Respiratory Syncytial Virus Vaccines by Regions
4.1 Respiratory Syncytial Virus Vaccines Market Size by Regions (2017-2022)
4.2 Americas Respiratory Syncytial Virus Vaccines Market Size Growth (2017-2022)
4.3 APAC Respiratory Syncytial Virus Vaccines Market Size Growth (2017-2022)
4.4 Europe Respiratory Syncytial Virus Vaccines Market Size Growth (2017-2022)
4.5 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Growth (2017-2022)
5 Americas
5.1 Americas Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022)
5.2 Americas Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2022)
5.3 Americas Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Respiratory Syncytial Virus Vaccines Market Size by Region (2017-2022)
6.2 APAC Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2022)
6.3 APAC Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Respiratory Syncytial Virus Vaccines by Country (2017-2022)
7.2 Europe Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2022)
7.3 Europe Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Respiratory Syncytial Virus Vaccines by Region (2017-2022)
8.2 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2022)
8.3 Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Respiratory Syncytial Virus Vaccines Market Forecast
10.1 Global Respiratory Syncytial Virus Vaccines Forecast by Regions (2023-2028)
10.1.1 Global Respiratory Syncytial Virus Vaccines Forecast by Regions (2023-2028)
10.1.2 Americas Respiratory Syncytial Virus Vaccines Forecast
10.1.3 APAC Respiratory Syncytial Virus Vaccines Forecast
10.1.4 Europe Respiratory Syncytial Virus Vaccines Forecast
10.1.5 Middle East & Africa Respiratory Syncytial Virus Vaccines Forecast
10.2 Americas Respiratory Syncytial Virus Vaccines Forecast by Country (2023-2028)
10.2.1 United States Respiratory Syncytial Virus Vaccines Market Forecast
10.2.2 Canada Respiratory Syncytial Virus Vaccines Market Forecast
10.2.3 Mexico Respiratory Syncytial Virus Vaccines Market Forecast
10.2.4 Brazil Respiratory Syncytial Virus Vaccines Market Forecast
10.3 APAC Respiratory Syncytial Virus Vaccines Forecast by Region (2023-2028)
10.3.1 China Respiratory Syncytial Virus Vaccines Market Forecast
10.3.2 Japan Respiratory Syncytial Virus Vaccines Market Forecast
10.3.3 Korea Respiratory Syncytial Virus Vaccines Market Forecast
10.3.4 Southeast Asia Respiratory Syncytial Virus Vaccines Market Forecast
10.3.5 India Respiratory Syncytial Virus Vaccines Market Forecast
10.3.6 Australia Respiratory Syncytial Virus Vaccines Market Forecast
10.4 Europe Respiratory Syncytial Virus Vaccines Forecast by Country (2023-2028)
10.4.1 Germany Respiratory Syncytial Virus Vaccines Market Forecast
10.4.2 France Respiratory Syncytial Virus Vaccines Market Forecast
10.4.3 UK Respiratory Syncytial Virus Vaccines Market Forecast
10.4.4 Italy Respiratory Syncytial Virus Vaccines Market Forecast
10.4.5 Russia Respiratory Syncytial Virus Vaccines Market Forecast
10.5 Middle East & Africa Respiratory Syncytial Virus Vaccines Forecast by Region (2023-2028)
10.5.1 Egypt Respiratory Syncytial Virus Vaccines Market Forecast
10.5.2 South Africa Respiratory Syncytial Virus Vaccines Market Forecast
10.5.3 Israel Respiratory Syncytial Virus Vaccines Market Forecast
10.5.4 Turkey Respiratory Syncytial Virus Vaccines Market Forecast
10.5.5 GCC Countries Respiratory Syncytial Virus Vaccines Market Forecast
10.6 Global Respiratory Syncytial Virus Vaccines Forecast by Type (2023-2028)
10.7 Global Respiratory Syncytial Virus Vaccines Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Pfizer Inc.Pfizer Inc.
11.1.1 Pfizer Inc.Pfizer Inc. Company Information
11.1.2 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Product Offered
11.1.3 Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Pfizer Inc.Pfizer Inc. Main Business Overview
11.1.5 Pfizer Inc.Pfizer Inc. Latest Developments
11.2 Sanofi
11.2.1 Sanofi Company Information
11.2.2 Sanofi Respiratory Syncytial Virus Vaccines Product Offered
11.2.3 Sanofi Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Sanofi Main Business Overview
11.2.5 Sanofi Latest Developments
11.3 Merck Sharp & Dohme
11.3.1 Merck Sharp & Dohme Company Information
11.3.2 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Product Offered
11.3.3 Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Merck Sharp & Dohme Main Business Overview
11.3.5 Merck Sharp & Dohme Latest Developments
11.4 GlaxoSmithKline
11.4.1 GlaxoSmithKline Company Information
11.4.2 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Product Offered
11.4.3 GlaxoSmithKline Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 GlaxoSmithKline Main Business Overview
11.4.5 GlaxoSmithKline Latest Developments
11.5 SOBI
11.5.1 SOBI Company Information
11.5.2 SOBI Respiratory Syncytial Virus Vaccines Product Offered
11.5.3 SOBI Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 SOBI Main Business Overview
11.5.5 SOBI Latest Developments
11.6 Johnson & Johnson
11.6.1 Johnson & Johnson Company Information
11.6.2 Johnson & Johnson Respiratory Syncytial Virus Vaccines Product Offered
11.6.3 Johnson & Johnson Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Johnson & Johnson Main Business Overview
11.6.5 Johnson & Johnson Latest Developments
11.7 Bavarian Nordic
11.7.1 Bavarian Nordic Company Information
11.7.2 Bavarian Nordic Respiratory Syncytial Virus Vaccines Product Offered
11.7.3 Bavarian Nordic Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Bavarian Nordic Main Business Overview
11.7.5 Bavarian Nordic Latest Developments
11.8 Novavax
11.8.1 Novavax Company Information
11.8.2 Novavax Respiratory Syncytial Virus Vaccines Product Offered
11.8.3 Novavax Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Novavax Main Business Overview
11.8.5 Novavax Latest Developments
11.9 AstraZeneca
11.9.1 AstraZeneca Company Information
11.9.2 AstraZeneca Respiratory Syncytial Virus Vaccines Product Offered
11.9.3 AstraZeneca Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 AstraZeneca Main Business Overview
11.9.5 AstraZeneca Latest Developments
11.10 Moderna
11.10.1 Moderna Company Information
11.10.2 Moderna Respiratory Syncytial Virus Vaccines Product Offered
11.10.3 Moderna Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Moderna Main Business Overview
11.10.5 Moderna Latest Developments
11.11 Codagenix
11.11.1 Codagenix Company Information
11.11.2 Codagenix Respiratory Syncytial Virus Vaccines Product Offered
11.11.3 Codagenix Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Codagenix Main Business Overview
11.11.5 Codagenix Latest Developments
11.12 Intravacc
11.12.1 Intravacc Company Information
11.12.2 Intravacc Respiratory Syncytial Virus Vaccines Product Offered
11.12.3 Intravacc Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Intravacc Main Business Overview
11.12.5 Intravacc Latest Developments
11.13 Alphavax
11.13.1 Alphavax Company Information
11.13.2 Alphavax Respiratory Syncytial Virus Vaccines Product Offered
11.13.3 Alphavax Respiratory Syncytial Virus Vaccines Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Alphavax Main Business Overview
11.13.5 Alphavax Latest Developments
12 Research Findings and Conclusion
Table 1. Respiratory Syncytial Virus Vaccines Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Palivizumab
Table 3. Major Players of RSVpreF PF06928316
Table 4. Major Players of RSVPreF3 OA (GSK3844766A)
Table 5. Major Players of mRNA-1345
Table 6. Major Players of Janssen RSV Vaccine
Table 7. Major Players of ResVax
Table 8. Major Players of Nirsevimab (MEDI8897)
Table 9. Major Players of MVA-BN RSV
Table 10. Respiratory Syncytial Virus Vaccines Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 11. Global Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 12. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2017-2022)
Table 13. Respiratory Syncytial Virus Vaccines Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 14. Global Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 15. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2017-2022)
Table 16. Global Respiratory Syncytial Virus Vaccines Revenue by Players (2020-2022) & ($ Millions)
Table 17. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Player (2020-2022)
Table 18. Respiratory Syncytial Virus Vaccines Key Players Head office and Products Offered
Table 19. Respiratory Syncytial Virus Vaccines Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 20. New Products and Potential Entrants
Table 21. Mergers & Acquisitions, Expansion
Table 22. Global Respiratory Syncytial Virus Vaccines Market Size by Regions 2017-2022 & ($ Millions)
Table 23. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Regions (2017-2022)
Table 24. Americas Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022) & ($ Millions)
Table 25. Americas Respiratory Syncytial Virus Vaccines Market Size Market Share by Country (2017-2022)
Table 26. Americas Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 27. Americas Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2017-2022)
Table 28. Americas Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 29. Americas Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2017-2022)
Table 30. APAC Respiratory Syncytial Virus Vaccines Market Size by Region (2017-2022) & ($ Millions)
Table 31. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Region (2017-2022)
Table 32. APAC Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 33. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2017-2022)
Table 34. APAC Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 35. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2017-2022)
Table 36. Europe Respiratory Syncytial Virus Vaccines Market Size by Country (2017-2022) & ($ Millions)
Table 37. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Country (2017-2022)
Table 38. Europe Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 39. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2017-2022)
Table 40. Europe Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 41. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2017-2022)
Table 42. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Region (2017-2022) & ($ Millions)
Table 43. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Region (2017-2022)
Table 44. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Type (2017-2022) & ($ Millions)
Table 45. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Type (2017-2022)
Table 46. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size by Application (2017-2022) & ($ Millions)
Table 47. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Application (2017-2022)
Table 48. Key Market Drivers & Growth Opportunities of Respiratory Syncytial Virus Vaccines
Table 49. Key Market Challenges & Risks of Respiratory Syncytial Virus Vaccines
Table 50. Key Industry Trends of Respiratory Syncytial Virus Vaccines
Table 51. Global Respiratory Syncytial Virus Vaccines Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 52. Global Respiratory Syncytial Virus Vaccines Market Size Market Share Forecast by Regions (2023-2028)
Table 53. Global Respiratory Syncytial Virus Vaccines Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 54. Global Respiratory Syncytial Virus Vaccines Market Size Market Share Forecast by Type (2023-2028)
Table 55. Global Respiratory Syncytial Virus Vaccines Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 56. Global Respiratory Syncytial Virus Vaccines Market Size Market Share Forecast by Application (2023-2028)
Table 57. Pfizer Inc.Pfizer Inc. Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 58. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Product Offered
Table 59. Pfizer Inc.Pfizer Inc. Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Pfizer Inc.Pfizer Inc. Main Business
Table 61. Pfizer Inc.Pfizer Inc. Latest Developments
Table 62. Sanofi Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 63. Sanofi Respiratory Syncytial Virus Vaccines Product Offered
Table 64. Sanofi Main Business
Table 65. Sanofi Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Sanofi Latest Developments
Table 67. Merck Sharp & Dohme Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 68. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Product Offered
Table 69. Merck Sharp & Dohme Main Business
Table 70. Merck Sharp & Dohme Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Merck Sharp & Dohme Latest Developments
Table 72. GlaxoSmithKline Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 73. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Product Offered
Table 74. GlaxoSmithKline Main Business
Table 75. GlaxoSmithKline Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. GlaxoSmithKline Latest Developments
Table 77. SOBI Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 78. SOBI Respiratory Syncytial Virus Vaccines Product Offered
Table 79. SOBI Main Business
Table 80. SOBI Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. SOBI Latest Developments
Table 82. Johnson & Johnson Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 83. Johnson & Johnson Respiratory Syncytial Virus Vaccines Product Offered
Table 84. Johnson & Johnson Main Business
Table 85. Johnson & Johnson Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Johnson & Johnson Latest Developments
Table 87. Bavarian Nordic Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 88. Bavarian Nordic Respiratory Syncytial Virus Vaccines Product Offered
Table 89. Bavarian Nordic Main Business
Table 90. Bavarian Nordic Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Bavarian Nordic Latest Developments
Table 92. Novavax Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 93. Novavax Respiratory Syncytial Virus Vaccines Product Offered
Table 94. Novavax Main Business
Table 95. Novavax Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Novavax Latest Developments
Table 97. AstraZeneca Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 98. AstraZeneca Respiratory Syncytial Virus Vaccines Product Offered
Table 99. AstraZeneca Main Business
Table 100. AstraZeneca Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. AstraZeneca Latest Developments
Table 102. Moderna Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 103. Moderna Respiratory Syncytial Virus Vaccines Product Offered
Table 104. Moderna Main Business
Table 105. Moderna Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 106. Moderna Latest Developments
Table 107. Codagenix Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 108. Codagenix Respiratory Syncytial Virus Vaccines Product Offered
Table 109. Codagenix Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. Codagenix Main Business
Table 111. Codagenix Latest Developments
Table 112. Intravacc Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 113. Intravacc Respiratory Syncytial Virus Vaccines Product Offered
Table 114. Intravacc Main Business
Table 115. Intravacc Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 116. Intravacc Latest Developments
Table 117. Alphavax Details, Company Type, Respiratory Syncytial Virus Vaccines Area Served and Its Competitors
Table 118. Alphavax Respiratory Syncytial Virus Vaccines Product Offered
Table 119. Alphavax Main Business
Table 120. Alphavax Respiratory Syncytial Virus Vaccines Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 121. Alphavax Latest Developments
List of Figures
Figure 1. Respiratory Syncytial Virus Vaccines Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Respiratory Syncytial Virus Vaccines Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Type in 2021
Figure 7. Respiratory Syncytial Virus Vaccines in Hospital
Figure 8. Global Respiratory Syncytial Virus Vaccines Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Respiratory Syncytial Virus Vaccines in Clinic
Figure 10. Global Respiratory Syncytial Virus Vaccines Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Respiratory Syncytial Virus Vaccines in Research Institute
Figure 12. Global Respiratory Syncytial Virus Vaccines Market: Research Institute (2017-2022) & ($ Millions)
Figure 13. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Application in 2021
Figure 14. Global Respiratory Syncytial Virus Vaccines Revenue Market Share by Player in 2021
Figure 15. Global Respiratory Syncytial Virus Vaccines Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Respiratory Syncytial Virus Vaccines Market Size 2017-2022 ($ Millions)
Figure 17. APAC Respiratory Syncytial Virus Vaccines Market Size 2017-2022 ($ Millions)
Figure 18. Europe Respiratory Syncytial Virus Vaccines Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size 2017-2022 ($ Millions)
Figure 20. Americas Respiratory Syncytial Virus Vaccines Value Market Share by Country in 2021
Figure 21. Americas Respiratory Syncytial Virus Vaccines Consumption Market Share by Type in 2021
Figure 22. Americas Respiratory Syncytial Virus Vaccines Market Size Market Share by Application in 2021
Figure 23. United States Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Region in 2021
Figure 28. APAC Respiratory Syncytial Virus Vaccines Market Size Market Share by Application in 2021
Figure 29. China Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Country in 2021
Figure 36. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Type in 2021
Figure 37. Europe Respiratory Syncytial Virus Vaccines Market Size Market Share by Application in 2021
Figure 38. Germany Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size Market Share by Application in 2021
Figure 46. Egypt Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Respiratory Syncytial Virus Vaccines Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 52. APAC Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 53. Europe Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 55. United States Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 56. Canada Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 59. China Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 60. Japan Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 61. Korea Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 63. India Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 64. Australia Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 65. Germany Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 66. France Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 67. UK Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 68. Italy Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 69. Russia Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 70. Spain Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 73. Israel Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Respiratory Syncytial Virus Vaccines Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
